QL
EWTX icon

Quarry LP’s Edgewise Therapeutics EWTX Stock Holding History

Quarry LP’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88K Sell
71
-5,929
-99% -$204K ﹤0.01% 1395
2026
Q1 		$189K Buy
6,000
+200
+3% +$5.77K 0.03% 347
2025
Q4 		$144K Buy
+5,800
New +$116K 0.02% 336
2025
Q3 		– Sell
-311
Closed -$4.08K – 2269
2025
Q2 		$4.08K Sell
311
-889
-74% -$12.8K ﹤0.01% 1496
2025
Q1 		$26.4K Sell
1,200
-800
-40% -$21K 0.01% 1039
2024
Q4 		$53.4K Sell
2,000
-1,500
-43% -$47.8K 0.01% 718
2024
Q3 		$93.4K Sell
3,500
-10,500
-75% -$209K 0.02% 452
2024
Q2 		$252K Buy
+14,000
New +$244K 0.07% 131

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quarry LP's EWTX Position: Q2 2026 in Review

Quarry LP reduced its Edgewise Therapeutics (EWTX) stake by 99% in Q2 2026, selling an estimated $204K and leaving 71 shares worth $2.88K. The position accounts for ﹤0.01% of the portfolio, ranked #1395.

Quarry LP first reported a position in EWTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $252K in Q2 2024. 227 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Quarry LP held 71 shares of Edgewise Therapeutics worth $2.88K as of Q2 2026.
  • Quarry LP sold 5,929 Edgewise Therapeutics shares in Q2 2026, an estimated $204K.
  • Edgewise Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1395 holding.
  • Quarry LP first reported a position in Edgewise Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Quarry LP's Edgewise Therapeutics position peaked at $252K in Q2 2024.
  • 227 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.